总时间（秒）：10.20
问答时间（秒）：9.42

Here is the extracted and standardized information in JSON format:

```
{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_004800.4:c.1621delT",
          "cDNA Change": {
            "transcript": "NM_004800.4",
            "ref": "N/A",
            "alt": "delT",
            "position": "1621"
          },
          "Protein Change": {
            "ref": "N/A",
            "alt": "N/A",
            "position": "N/A"
          },
          "Description in input context": "c.1621delT (p.K538fs)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal Recessive Juvenile Parkinsonism (AR-JP)",
    "MONDO": "MONDO:0012346"
  },
  "Experiment Method": [
    {
      "Assay Method": "Ubiquitin-protein ligase assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells expressing Parkin protein",
        "Description": "The experiment was conducted using HEK293 cells expressing Parkin protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004800.4:c.1621delT",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Ubiquitin-protein ligase activity was reduced by 30% for the variant NM_004800.4:c.1621delT."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N/A"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type Parkin protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitin-protein ligase activity greater than 80%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitin-protein ligase activity less than 50%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    }
  ]
}
```

Note that some of the fields may be empty or have values "N/A" as they were not explicitly mentioned in the provided literature.